Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene

Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene

Show other versions (1)

A single-nucleotide polymorphism (SNP) upstream of interleukin (IL)28B was recently identified as an important predictor of the outcome of chronic hepatitis C patients treated with pegylated interferon plus ribavirin (PEG-IFN/RBV). The aim of this study was to investigate the association between the...

Full description

Bibliographic Details
Main Authors:	Tarciana Grandi, Cláudia Maria Dornelles da Silva, Karine Medeiros Amaral, Paulo Dornelles Picon, Cintia Costi, Nicole Nascimento da Fré, Marilu Fiegenbaum, Christian Niel, Maria Lucia Rosa Rossetti
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 2013-02-01
Series:	Memorias do Instituto Oswaldo Cruz
Subjects:	IL28B HCV virological response treatment Brazil
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100008&lng=en&tlng=en

Similar Items

Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
by: Tarciana Grandi, et al.
Published: (2013-02-01)

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients
by: Tarciana Grandi, et al.
Published: (2014-06-01)

Polymorphism of Interleukin 28 and HCV: Implementation of a method
by: Alessandra Flaminio, et al.
Published: (2012-12-01)

Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin
by: Osamu Yokosuka, et al.
Published: (2012-08-01)

Prevalence of hepatitis C virus and human immunodeficiency virus in a group of patients newly diagnosed with active tuberculosis in Porto Alegre, Southern Brazil
by: Cintia Costi, et al.

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

Impact of the IL-18 gene polymorphism in response to antiviral therapy in chronic HCV genotype 4 patients
by: Mohamed Mandour, et al.
Published: (2014-04-01)

Interleukin-27 levels and its Polymorphism in Hepatocellular carcinoma associated with Hepatitis C
by: Nahla Anber, et al.
Published: (2020-02-01)

Effectiveness of Combination Therapy of Sofosbuvir and Daclatasvir in Hepatitis C Positive Hemodialysis Patients Presenting to a Tertiary Care Hospital
by: Qurat Ul Ain, et al.
Published: (2023-10-01)

Treatment of hepatitis C virus infection: From therapy with interferon to direct-acting antivirals
by: Laura Lopera, et al.
Published: (2023-01-01)

Immunological Aspects of ELISA Positive PCR Negative Newly Diagnosed Hepatitis C Patients in Kirkuk Province
by: Muhannad Abdullah Al-Azzawy
Published: (2022-12-01)

Hepatitis C Virus Infection Outcomes Among Immigrants to Canada: A Retrospective Cohort Analysis
by: Curtis L. Cooper, et al.
Published: (2017-09-01)

Paradoxical expression of <it>IL-28B </it>mRNA in peripheral blood in human T-cell leukemia virus Type-1 mono-infection and co-infection with hepatitis C Virus
by: Kamihira Shimeru, et al.
Published: (2012-02-01)

Pivotal Role of Serum IL-37 In Patients with Chronic HBV and HCV
by: Ellaf Abdulljabbar Al-Jaryan, et al.
Published: (2023-09-01)

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
by: Ghada M. Salum, et al.
Published: (2020-09-01)

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
by: Anita Y.M. Howe, et al.
Published: (2022-05-01)

IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals
by: Nancy Abdel Fattah Ahmed, et al.
Published: (2021-05-01)

Levels of interleukins 12 (IL-12) and 13 (IL-13), hepatitis B and C serology, and blood cultures among acute myeloid leukemia (AML) patients in Egypt
by: Nour el deen RAA, et al.
Published: (2011-01-01)

Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis
by: Amira Youssef Shaala, et al.
Published: (2015-09-01)

Contemporary Insights into Hepatitis C Virus: A Comprehensive Review
by: Malik Sallam, et al.
Published: (2024-05-01)

Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients
by: Crina Fofiu, et al.
Published: (2019-01-01)

Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease
Published: (2006-04-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

Early on-treatment plasma interleukin-18 as a promising indicator for long-term virological response in patients with HIV-1 infection
by: Weiyin Lin, et al.
Published: (2023-06-01)

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
by: Younossi Zobair M, et al.
Published: (2012-02-01)

Genetic variation in Interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin
by: Ezequiel Ridruejo, et al.
Published: (2011-10-01)

The Genetic Profile and Serum Level of IL-8 Are Associated with Chronic Hepatitis B and C Virus Infection
by: Ednelza da Silva Graça Amoras, et al.
Published: (2021-11-01)

Interleukin -6 and C- reactive protein profiles in Hepatitis C virus patients
by: Abbas Arrak Abbas al-Tamimi
Published: (2012-12-01)

Effect of directly acting anti-viral agents on immunological imprints in chronic HCV-4a patients: interleukin-10 and vascular endothelial growth factor genes expression level
by: Iman S. Naga, et al.
Published: (2021-05-01)

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs)
by: Lorenza Di Marco, et al.
Published: (2025-01-01)

A CURE FOR RECENTLY ACQUIRED HEPATITIS C
by: Radka Komitova, et al.
Published: (2022-12-01)

Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China
by: Yunjing Zhou, et al.
Published: (2024-02-01)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
by: Steven Flamm, et al.
Published: (2023-09-01)

Can hepatitis C virus core antigen replace quantitative RNA in the assessment of a sustained virologic response?
by: Nevine I Musa, et al.
Published: (2019-01-01)

The Predictive Factors for Favorable Outcomes of Peginterferon and Ribavirin Combination Therapy in HCV-Infected Patients
by: Javad Moayedi, et al.
Published: (2020-08-01)

The impact of IL-6 and IL-28B gene polymorphisms on treatment outcome of chronic hepatitis C infection among intravenous drug users in Croatia
by: Zoran Bogdanović, et al.
Published: (2016-10-01)

A review on interleukins (IL10 and IL17) as biomarkers for hepatitis C-associated oral lichen planus
by: Suraiya Hirani, et al.
Published: (2022-08-01)

Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
by: Jiménez-Sousa María A, et al.
Published: (2013-01-01)

Hepcidin serum levels in HCV chronically mono-infected naïve patients, compared to healthy individuals
by: Ari Ben Hur Stefani Leao, et al.
Published: (2018-07-01)

Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rsI2979860 polymorphism of the <it>IL28B </it>gene
by: Lutz P, et al.
Published: (2011-08-01)